Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-11

Clinical Trial Update: Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating therapeutic targets beyond inflammation for Crohn's disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Crohn Disease (CD) | Phase 2 | Status: RECRUITING